<- Go Home
Virbac SA
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Market Cap
EUR 2.5B
Volume
3.8K
Cash and Equivalents
EUR 149.6M
EBITDA
EUR 272.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 941.3M
Profit Margin
67.36%
52 Week High
EUR 400.00
52 Week Low
EUR 289.50
Dividend
0.49%
Price / Book Value
2.36
Price / Earnings
16.93
Price / Tangible Book Value
4.77
Enterprise Value
EUR 2.6B
Enterprise Value / EBITDA
9.17
Operating Income
EUR 226.6M
Return on Equity
14.93%
Return on Assets
8.57
Cash and Short Term Investments
EUR 153.9M
Debt
EUR 312.8M
Equity
EUR 1.0B
Revenue
EUR 1.4B
Unlevered FCF
EUR 75.9M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium